Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Docusign (NASDAQ:DOCU) Shares Gap Up - Should You Buy?

Docusign logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Docusign shares gapped up after opening above the prior close, moving from $49.02 to $51.13 before settling around $50.96. The stock’s recent rise comes despite a mixed longer-term trading profile, with its 50-day average below the current price but its 200-day average higher.
  • Analyst sentiment remains cautious overall: Docusign has an average Hold rating, with a consensus price target of $61.40. Recent actions included downgrades and lower price targets from firms like Weiss Ratings, RBC, Wells Fargo, and Bank of America.
  • The company reported solid quarterly results and approved a $2 billion share repurchase plan, signaling confidence in its valuation. Earnings came in above expectations, revenue rose 7.8% year over year, and the buyback could cover up to 21% of outstanding shares.
  • Five stocks to consider instead of Docusign.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $49.02, but opened at $51.13. Docusign shares last traded at $50.9560, with a volume of 578,249 shares traded.

Analysts Set New Price Targets

A number of research firms have recently issued reports on DOCU. Weiss Ratings downgraded Docusign from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, April 15th. Needham & Company LLC reiterated a "hold" rating on shares of Docusign in a research note on Tuesday, March 10th. Royal Bank Of Canada dropped their price objective on shares of Docusign from $70.00 to $55.00 and set a "sector perform" rating on the stock in a research note on Wednesday, March 18th. Wells Fargo & Company cut their price target on Docusign from $75.00 to $60.00 and set an "equal weight" rating on the stock in a report on Wednesday, March 18th. Finally, Bank of America began coverage on Docusign in a research report on Tuesday, March 31st. They set an "underperform" rating and a $52.00 price objective on the stock. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $61.40.

View Our Latest Stock Report on Docusign

Docusign Price Performance

The firm has a market cap of $9.55 billion, a price-to-earnings ratio of 33.22, a P/E/G ratio of 1.82 and a beta of 0.88. The firm has a fifty day simple moving average of $46.90 and a two-hundred day simple moving average of $55.96.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. During the same period in the previous year, the firm posted $0.86 earnings per share. The business's revenue for the quarter was up 7.8% compared to the same quarter last year. Equities analysts anticipate that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.

Docusign announced that its board has approved a stock repurchase plan on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 21% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board believes its shares are undervalued.

Insider Buying and Selling

In other Docusign news, Director Mary Agnes Wilderotter sold 3,000 shares of the company's stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $48.15, for a total value of $144,450.00. Following the sale, the director directly owned 59,803 shares of the company's stock, valued at approximately $2,879,514.45. This represents a 4.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Robert Chatwani sold 16,696 shares of the company's stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $48.10, for a total transaction of $803,077.60. Following the completion of the sale, the insider directly owned 72,458 shares in the company, valued at approximately $3,485,229.80. The trade was a 18.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 64,673 shares of company stock valued at $3,077,699 in the last 90 days. 0.59% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Docusign

Several large investors have recently made changes to their positions in DOCU. Bank of America Corp DE boosted its stake in shares of Docusign by 23.3% during the 1st quarter. Bank of America Corp DE now owns 1,193,163 shares of the company's stock worth $56,568,000 after acquiring an additional 225,801 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of Docusign by 422.7% during the 1st quarter. Janus Henderson Group PLC now owns 97,110 shares of the company's stock worth $4,603,000 after acquiring an additional 78,530 shares in the last quarter. Centaurus Financial Inc. boosted its stake in shares of Docusign by 7.9% during the 1st quarter. Centaurus Financial Inc. now owns 27,209 shares of the company's stock worth $1,290,000 after acquiring an additional 1,992 shares in the last quarter. Bull Harbor Capital LLC purchased a new stake in shares of Docusign during the 1st quarter worth about $420,000. Finally, Amundi boosted its stake in shares of Docusign by 19.7% during the 1st quarter. Amundi now owns 1,036,657 shares of the company's stock worth $49,148,000 after acquiring an additional 170,299 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About Docusign

(Get Free Report)

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines